Sentences with phrase «drug pricing pressures»

The report eased concerns about the company's ability to withstand fallout from drug pricing pressures that have been a headwind for the industry.

This is a hefty price tag yet may be necessary to compete in the increasingly competitive healthcare space in the face of drug pricing pressures.

Acquiring Akorn would add around $ 1 billion in annual sales to Fresenius» drugmaking division, giving it a significantly larger presence in eyecare and other areas widely perceived as somewhat insulated from generic drug pricing pressure.

Not exact matches

With its traditional insulin treatments in the firing line due to U.S. price pressure, Novo Nordisk is pinning hopes for growth on new obesity drugs and a once - weekly injection and tablet version of its semaglutide drug.

Branded drug price deflation and fewer expected new drug launches continue to put pressure on industry profits, and AmerisourceBergen has been working to counter those effects.

Generic drug giant Mylan is cutting its financial outlook as it continues to face pressure from falling generic drug prices (a fate that similarly struck rival Teva Pharmaceuticals).

Drug prices come under pressure.

Given its areas of specialization, Gilead wouldn't benefit as much from consolidation as, say, a generic - drug company would, but it still faces pricing pressure: To appease Medicaid and other insurers, Gilead is already steeply discounting its hep - C drugs, which can cost more than $ 80,000 for a 12 - week course.

MÅLOV, Denmark, Nov 21 (Reuters)- Danish drugmaker Novo Nordisk is stepping up its efforts to treat obesity, seeking to tap into a potentially huge market as prices for its established diabetes drugs come under pressure, particularly in the United States.

MÅLOV, Denmark, Nov 21 - Danish drugmaker Novo Nordisk is stepping up its efforts to treat obesity, seeking to tap into a potentially huge market as its established diabetes drugs come under price pressure, particularly in the United States.

In addition to the potential for medical breakthrough, most analysts who spoke with CNBC also noted that cancer drugs are not subject to increased political pressure to lower prices.

House Democrats have started what they called an «in - depth» investigation into the pricing of drugs for neurological condition multiple sclerosis, the latest attempt by U.S. politicians to pressure manufacturers to lower costs.

The mid-afternoon rally was rather inclusive, but still featured some notable exceptions, with the drug and other health - care providers under continuing pressure from government jaw - boning about pricing.

Last year, as pressure mounted on the pharmaceutical industry after a series of high profile cases involving skyrocketing prices, drug companies spent roughly $ 800,000 lining campaign coffers in Albany.

These include patent expirations, the rise of competition from generics, a downward pressure on drug prices, increasing scrutiny from regulators and health technology assessment bodies, pressure to move research offshore, and the crisis in R&D productivity.

Skyrocketing drugs prices are increasing pressure on an already troubled NHS and becoming a barrier to bringing new therapies to patients.

In her book The Price of Privilege, Madeline Levine described many of these students, privately stressed out by parental pressure, misguided by peer group injunctions and expectations, and not infrequently abusing drugs and / or alcohol.

Politicians may pressure them to lower U.S. drug prices, but the stocks already reflect this risk.

In such patients, low priced generic risk pills that combine aspirin with a statin drug in order to reduce cholesterol and lower blood pressure can bring down the chances of suffering another stroke or even dying by two - thirds.

The pharmaceutical industry is under pressure from every corner, with expiring patents on blockbuster drugs, research and development productivity on the wane and constant negative pricing pressure forcing the need to rationalise.